Andrew M. is a senior leader with over 20 years of experience managing global pre-clinical and clinical programs in CRO and Pharma environments. His expertise lies in biotherapeutics, with a significant focus on Immuno-Oncology. Holding a PhD from the University of Liverpool, he is described by colleagues as dedicated, dynamic, and innovative.
He has successfully architected and led the worldwide translational strategy for at least 30 major drug development programs from early development through to late-stage trials.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.